Despite emergency coronary revascularization coupled with medical stabilization, intra-aortic balloon pump and ventricular assist devices have significantly improved survival in patients with cardiogenic shock complicating acute myocardial infarction, mortality still remains excessively high, being actually about 30-40%. Future research should focus on new therapeutic strategies, aimed to further decrease mortality rate of these patients.